Dr Michal Lubomski is a neurologist with a specialist interest in Movement Disorders, particularly in the use of device assisted therapies for Parkinson’s disease. He is completing his PhD at the Kolling Institute, University of Sydney investigating the gastrointestinal microbiome in Parkinson’s disease, supervised by Prof Carolyn Sue and Dr Ryan Davis. Michal’s research has attracted funding from Parkinson’s NSW, The Royal Australasian College of Physici ans and The University of Sydney. Michal is a Clinical Senior Lecturer, having completed his Medical Degree at the University of Notre Dame, Sydney. He is currently working at the Prince of Wales and Royal North Shore Hospitals, having previously undertak en his Neurology training at St Vincent’s, Concord and Royal Prince Alfred Hospitals and subsequently completing his Fellowship at Royal North Shore Hospital. His future interests aim to bridge neurodegenerative scientific research into clinical practice.